Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value per share (the "Shares")
-
Shares outstanding
-
7,179,159
-
Total 13F shares
-
12,427
-
Share change
-
+12,427
-
Total reported value
-
$136,489
-
Price per share
-
$11.00
-
Number of holders
-
12
-
Value change
-
+$136,489
-
Number of buys
-
12
Institutional Holders of BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX) as of Q3 2025
As of 30 Sep 2025,
BriaCell Therapeutics Corp. - Common Shares, no par value per share (the "Shares") (BCTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,427 shares.
The largest 10 holders included
CITADEL ADVISORS LLC, Federation des caisses Desjardins du Quebec, MORGAN STANLEY, ROYAL BANK OF CANADA, SBI Securities Co., Ltd., GROUP ONE TRADING LLC, UBS Group AG, TD Waterhouse Canada Inc., Allworth Financial LP, and OSAIC HOLDINGS, INC..
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.